NCT05540574View on ClinicalTrials.gov

Trial of Zolpidem for Sleep in Children With Autism

PHASE2RecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
AutismAutism Spectrum Disorder
Interventions
DRUG

Zolpidem

5mg (and up to10mg) Diphenhydramine given orally

DRUG

Placebo

Matching Placebo given orally

Trial Locations (1)

94305-5719

RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Stanford University

OTHER